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A bstract
Background: Urinary incontinence affects approximately 5% (800.000) of the Dutch population. Guidelines recommend 
pelvic floor muscle/bladder training for most patients. Unfortunately, general practitioners use this training only 
incidentally, but prescribe incontinence pads. Over 50% of patients get such pads, costing €160 million each year. Due 
to ageing of the population a further increase of expenses is expected. Several national reports recommend to involve 
nurse specialists to support general practitioners and improve patient care. The main objective of our study is to 
investigate the effectiveness and cost-effectiveness of involving nurse specialists in primary care for urinary incontinence. 
This paper describes the study protocol.
Methods/Design: In a pragmatic prospective multi centre two-armed randomized controlled trial in the Netherlands 
the availability and involvement for the general practitioners of a nurse specialist will be compared with usual care. All 
consecutive patients consulting their general practitioner within 1 year for urinary incontinence and patients already 
diagnosed with urinary incontinence are eligible. Included patients will be followed for 12 months.
Primary outcome is severity of urinary incontinence (measured with the International Consultation on Incontinence 
Questionnaire Short Form (ICIQ-UI SF)). Based on ICIQ-UI SF outcome data the number of patients needed to include 
is 350. For the economic evaluation quality of life and costs will be measured alongside the clinical trial. For the longer 
term extrapolation of the economic evaluation a Markov modelling approach will be used.
Discussion/Conclusion: This is, to our knowledge, the first trial on care for patients with urinary incontinence in 
primary care that includes a full economic evaluation and cost-effectiveness modelling exercise from the societal 
perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is 
considered and anticipated.
Trial registration: Current Controlled Trials ISRCTN62722772
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Background 
Problem definition
The disease
Approximately 5% (800.000 people) o f  the D utch popu­
lation suffer from  urinary incontinence (UI) [1]. This con­
cerns predom inantly  w om en, and prevalence increases 
w ith age [2]. Am ong patients aged over 75, the prevalence 
rises up  to  30%. UI is infam ous for its im pact on  general 
well being and  social activities [3,4]. If n o t treated, UI is a 
chronic, n o t self-limiting disorder w ith a strong tendency 
to  worsen over time. It is one o f the m ost im portan t rea­
sons for institutionalisation o f elderly people in  nursing 
hom es.
The health care problem
In the Netherlands, annually €160  m illion  is spent on 
incontinence pads [1]. Considering the ageing o f the pop ­
u lation  a further increase in  these expenditures is expected 
[5-7]. Guidelines indicate tha t for m ost patients w ith UI 
pelvic floor muscle and /o r bladder training is the best 
non-invasive treatm ent to  solve the problem , rather than  
just com pensate the urine loss [2,5,6,8,9]. To date, despite 
guidelines, training is used only incidentally by general 
practitioners (GPs), probably because it is too  tim e con­
sum ing [5,6,8,10-12]. M ost GPs choose an easier, b u t 
non-curative and  ultim ately far m ore expensive, alterna­
tive: prescribing incontinence pads. More th an  50% of 
patients get incontinence pads, especially the elderly 
[1,12].
Usual care
For the vast m ajority o f  health  problem s in  the Dutch 
population , the GP is the initial person to  contact and is 
also the gatekeeper for specialist care. This also applies for 
UI. M ost patients (± 96% ) w ith UI are kept w ith in  prim ary 
care [9,13]. Only few patients (total < 5%) are referred to 
a specialist (in  m ost cases a urologist or gynaecologist) or 
a physical therapist [5,13]. N ational guidelines o n  UI are 
available for prim ary care [9,14]. These guidelines are fol­
lowed only incidentally, irrespective o f the type o f guide­
line or clinical problem  involved [10-12,15]. A m ajor 
reason why the guidelines are n o t used, may be because 
consultations take m ore tim e w hen following guidelines 
[5,16].
Motivation and relevance for the chosen intervention 
In recent years, there is a growing em phasis in  the Nether­
lands to  involve nurse specialists in  general practice w ith 
positive findings for chronic disorders [5,6,17,18]. Nurse 
specialists have specific expertise, and are capable of 
spending m ore tim e on  m otivating patients. Incorporat­
ing nurse specialists m ay offer a so lution to  the inade­
quate care for UI w ith inappropriate prescribing of 
incontinence pads. After special training, and  using their 
specific expertise on  UI, they are well equipped to support
the GP after the initial problem  definition by the GP. 
Their acceptance by patients and GPs, feasibility and use­
fulness in  m anagem ent, and  effectiveness in  treating UI 
have been reported [8,19-23]. However, to  our know l­
edge, studies w ith a full econom ic analysis and  cost-effec­
tiveness m odelling exercise from  the societal perspective 
o f  involving nurse specialists for UI are n o t available.
Objective
The m ain  objective is to  study w hether the availability and 
involvem ent o f a nurse specialist in  a new role as a substi­
tute for the GP in  the m anagem ent o f UI in  general prac­
tice leads to  m ore efficient care for adu lt UI patients. We 
envision that the effects o f the intervention will be such 
tha t care will improve, hence m ore patients can be treated 
effectively and  therefore will use less incontinence pads, 
w hich leads to  a reduction in  costs.
The following research questions were formulated:
1. Does the availability and  the involvem ent o f a nurse 
specialist as a substitute for the GP for adult persons w ith 
UI lead to  a reduction in  the severity o f  UI com pared to 
care as usual by the GP?
2. Does the involvem ent o f such a nurse specialist lead to 
a better quality o f  life o f the patients?
3. Is the involvem ent o f such a nurse specialist cost-effec­
tive com pared to  care as usual by the GP?
4: Does the involvem ent o f a nurse specialist on  UI lead to 
a better satisfaction o f patients, GPs and  other health  care 
providers?
5. To w hat extent do GPs use the nurse specialist?
6. W hat are reasons for the GPs for (not) using the nurse 
specialist? Does the availability o f the nurse specialist 
change the perception o f GPs about the treatm ent via the 
nurse specialist?
Methods/Design
This pragmatic prospective m ulti-centre two-arm ed rand­
om ized controlled trial is now  conducted am ong patients 
w ith UI in  general practices in  four regions in  the N ether­
lands. Initially, the trial was p lanned  to be conducted in  at 
least two regions (M aastricht and Nijmegen). During the 
preparation o f the trial expert key persons on  UI in  the 
regions o f H elm ond and The Hague expressed their w ill­
ingness to participate as well (see Figure 1). The study pro­
tocol is approved by the Medical Ethical Com m ittees o f all 
the involved medical centres and  hospitals. Patients will 
be random ized into an  experim ental group with availabil­
ity o f care by the nurse specialist o r a control group receiv-
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Inclusion criteria:
•SUI, UUI, mixed 
•Well versed in Dutch 
•Informed consent 
Exclusion criteria: 
•Specific pathology 
•Severe cognitive problems 
•Not motivated
Allocation
Follow up
12 months
Outcome 
Measures*# all
Cost- effectiveness 
analysis.
#  Time horizon: 
duration of 
lifespan of patients
F ig u re !
Study design. * Primary outcome measure: • severity urinary incontinence (ICIQ-UI SF) # Secundary outcom e m eas­
ures: 1. health care and productivity, time, travel costs. 2. generic QOL: EuroQol. 3. incontinence specific QOL: IIQ-7. 4. 
quantification of symptoms: bladder diary. 5. satisfaction of patients. 6. perceptions GPs and nurse specialists. $ needed number 
with and without drop-out/loss-to-follow up
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ing the usual care from  their GP. Included patients will be 
followed for 12 m onths.
The random ization process is concealed from  those 
responsible for recruiting patients using central telephone 
random ization. Because only a small num ber o f patients 
is to  be expected per GP, patients are random ized using a 
separate random ization  list for each participating region.
Blinding patients and  health  care providers is n o t possi­
ble. Personnel collecting outcom e data are b linded  to  the 
patients treatm ent allocation. A patient in  the control 
group can n o t be referred by the GP to use the route via 
the nurse specialist, to  avoid contam ination.
Study population
Inclusion criteria
All consecutive patients consulting their GP for sym ptom s 
and signs o f stress, urgency and mixed UI (according to 
the guidelines o f  the D utch College o f General Practition­
ers on  UI [9]) for a period o f one year and  UI patients 
diagnosed as such by the GPs in  the past are eligible for 
the study [9,24,25]. Patients w ho consult their GP for UI 
are actively recruited by the GP to participate in  the study. 
Known UI patients are selected by the GP on  eligibility 
and will be invited by the GP to participate in  the study. 
In case o f doub t by the GP o n  eligibility the patient will be 
invited for a consultation on  UI by the GP. Regularly and 
repeatedly, GPs will be stim ulated to  include patients for 
the study. Inform ation, rem inders and  newsletters are part 
o f the strategy to  enhance the GPs awareness o f the avail­
ability o f the nurse specialist and its potential benefits for 
this specific health  care.
Exclusion criteria
Excluded are patients below  18, w om en w ith prolapse 
degree III o r m ore, patients w ith signs o f reflex- or over­
flow incontinence, tum ours in  the abdom en, severe neu­
rological diseases associated w ith incontinence (m ultiple 
sclerosis, CVA, diabetes, cauda equina syndrom e), actual 
urinary tract infection, hem aturia w ithout urinary tract 
infection, m en below  65 w ith unexplained incontinence, 
patients w ith failure after operation  or failure o f  conserv­
ative therapy during the past h a lf year (or longer, provided 
there is no  relapse w hich causes dissatisfaction w ith the 
present situation), severe cognitive problem s, n o t well 
versed in  Dutch, refusing to participate/cooperate, 
patients for w hom  the GP considers the m anagem ent via 
the nurse specialist as im possible/undesired and  UI 
patients in  care and  nursing hom es.
Inform ed consent
After written inform ed consent all patients included have 
baseline data collection, urologic, obstetric and gynaeco- 
logic history in  w om en and urologic history in  m en. All
m easurem ents in  this study are perform ed by postal ques­
tionnaires m anaged by an  independent research-assistant.
Intervention(s)
The intervention is designed as close as possible to  treat­
m en t options in  clinical practice, including 'cascades' o f 
patien t m anagem ent choices (Figure 2). W hen the patient 
is allocated to  the intervention group the GP refers the 
patient to  the nurse specialist according to  a care protocol. 
All participating GPs are personally inform ed abou t the 
dem arcation and definition o f job responsibilities and 
com petence profile o f the nurse specialist towards GPs 
and other health  care professionals involved [26,27]. This 
inform ation is also available to the GP as w ritten inform a­
tion.
Training and competences o f  the nurse specialist [see 
Additional file 1]
The training program  for the nurse specialists how  to sup­
po rt the GP, by taking care o f  the diagnostic and therapeu­
tic m anagem ent o f patients w ith the m ost prevalent types 
o f  UI, is gradually developed during the preparation 
period o f the study. All nurse specialists will have to  prove 
their com petences in  an individual assessment.
Intervention nurse specialist [see Additional files 2 and 3]
The m ain  goal o f the intervention o f  the nurse specialist is 
to  provide a tailored, patient specific diagnostic and treat­
m ent plan, thereby preventing or reducing the use o f 
incontinence pads. Based o n  guidelines and  protocols the 
nurse specialist takes over tasks from  the GP related to 
diagnostics, intervention and  m onitoring o f patients with 
the m ost prevalent types o f UI (stress, urgency and  mixed 
UI) [28-31]. The GP keeps final responsibility. Further­
m ore, the nurse specialist supports patient m otivation, 
com pliance and  adherence b o th  on  the short and the long 
term  by m onitoring patients over tim e in  a systematic 
way. This ensures tha t patients will accept, understand, are 
willing and  able to  adhere to advices on  lifestyle, bladder- 
and pelvic floor muscle training according to  a health  edu­
cation m odel [22]. A nother task o f  the nurse specialist is 
to  give adequate inform ation and  advice abou t (w hen still 
necessary) the choice and the use o f non-curative m eans 
like incontinence pads. She/he will always report to  the 
GP and  acts as the contact person betw een the other 
healthcare providers. In case o f unclear pathology, a com ­
plex health  problem  or failure o f treatm ent the nurse spe­
cialist can advice a referral to  a specialist or specialised 
physical therapist. In all cases, the decision for referral is 
to  be m ade by the GP. Altogether this m eans that the 
nurse specialist will report to  the GP on  each patient after 
first problem  assessment and at the end o f  the interven­
tion  period. A regular m eeting betw een nurse specialist 
and GP to discuss patients will be organised w hen needed.
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60 minutes
1 week
3-5x weekly 
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20 minutes
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Figure 2
Flow  chart intervention nurse specialist fo r patients w ith U I. PFM (T) = Pelvic Floor Muscle (Training); GP = general 
practitioner; PPT = pelvic physiotherapist; NS = nurse specialist. The used terminology is according to the definitions as rec­
ommended by the International Continence Society.
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O utcom e measurements and data  collection
The prim ary outcom e measure is the severity o f involun­
tary loss o f urine. This is m easured by the self-completed 
condition specific International C onsultation on  Inconti­
nence Q uestionnaire Short Form (ICIQ-UI SF) which 
measures frequency, volum e and im pact on  daily life of 
involuntary urine loss [32,33]. The outcom e is a sum 
score o f  the first two weighted item s and  the Visual Ana­
logue Scale (VAS) score o f im pact on  daily life. The ques­
tionnaire underw ent extensive psychometric testing and is 
rated by the International Consultation on  Incontinence 
(ICI) as Grade A, m eaning highly recom m endable [3].
Secondary outcom e measures:
1. Generic quality o f life is m easured w ith the self-com­
pleted standardised EuroQol quality o f  life questionnaire 
(EQ-5D) [34]. It provides a simple descriptive profile, a 
single index value for health  status and  a VAS scale (0­
100). H ealth states defined by the 5-dim ensional descrip­
tive system can be converted in to  a weighted health  state 
index by applying scores from  EQ-5D "value sets" elicited 
from  general popu lation  samples.
2. Health care costs (the use o f diagnostics, treatm ent and 
incontinence pads) and non-m edical costs (productivity 
costs, tim e costs and travel costs) are collected using bo th  
registration systems and  retrospective cost questionnaires. 
Because o f recent literature and ow n experiences in  similar 
trials the use o f  these questionnaires was favoured above 
cost diaries [35-37].
3. Condition-specific quality o f  life is m easured with the 
self-completed International Incontinence Q uestionnaire 
(IIQ). For practical reasons we used the short form  o f this 
validated (7 item s) questionnaire tha t measures im pact of 
urinary loss on  five dom ains: 'm obility', 'physical func­
tioning', 'social functioning', 'em otional health ' and 
'em barrassm ent' [38,39].
4. Symptoms relevant for UI (the degree o f pad  usage, 
times o f m icturition, incontinence episodes, the degree of 
urgency, com plications, com plaints) is m easured w ith a 
self-completed bladder diary during 3 consecutive days 
[40-43]. Considering the restricted diagnostic value o f 
lower urinary tract sym ptom s (LUTS) for a final diagnosis 
(grade D) and  to  m inim ize complexity and  to  maximize 
com pliance (G ordon 2001) [3] to registration o f  the b lad­
der diary this registration will be restricted to  a m icturition 
tim e chart w ith the m ost relevant LUTS w hich give an 
im pression o f type, severity and im pact o f UI [3].
5. Patients' satisfaction w ith provided care for UI by the 
GP and /o r the nurse specialist was originally p lanned  to 
be m easured w ith the for UI adjusted QUOTE self-com­
pleted questionnaire. This showed to be n o t suitable to 
answer our research question. For this reason we devel­
oped a new questionnaire. For the developm ent o f the 
questionnaire topics relevant to  either the route via the 
nurse specialist or the usual care o f the GP were identified 
in  interviews w ith UI patients and experts in  the field par­
ticipating in  the study. We developed a set o f item s to  ena­
ble us to  m easure and test m ulti-item s scales. The items 
are related to  relevant them es w ith respect to  care for UI 
patients according to  standards on  UI.
6. Evaluation o f the availability and involvem ent o f the 
nurse specialist by GPs will be m easured by interviews and 
questionnaires after the study in  a sample o f the partici­
pating GPs. Data will be collected by a trained research 
assistant.
7. Evaluation by all participating nurse specialists on  role 
participation will be m easured by a semi-structured inter­
view and questionnaires before, during and after the 
study.
Data collection o f  all outcom e measures will be done at 3 
and 12 m onths. For the cost-effectiveness study extra fol­
low-up data collection o f the prim ary outcom e measure, 
costs and quality o f life will take place at 6 and 9 m onths. 
In case o f  non-response, telephone rem inders will take 
place two to  three weeks after sending the questionnaires. 
Adverse events/effects will be m onitored for the duration 
o f  the study.
Sam ple size calculation and feasibility o f recruitm ent
Based o n  a m ean score on  the ICIQ-UI SF [44] o f  7.18 (sd 
6.64), and an  expected im provem ent of 2 on  the outcom e 
scale from  0 to 21 (which gives a delta value o f 2 /6.64 = 
0.301), a pow er o f 80% and a significance level o f  0.05, 
and given the two-sided H1-hypothesis, th a t the new pro­
fessional im proves the effect, the needed num ber o f 
patients per arm  is 175 patients. We expect a d rop-out rate 
during the trial o f 20% and therefore we set our target at 
(rounded  off) 2 times 210 = 420 patients. As show n in 
previous D utch studies on  UI, GP practices are able to 
include 5 -1 0  patients per year. Therefore, we need 50 to 
88 GPs to participate. Recruitment o f  the needed num bers 
o f  patients seems highly feasible since the pow er calcula­
tion  was based on  the regions o f M aastricht and  Nijmegen 
alone (total num ber o f inhabitants: 500.000; total 
num ber o f GP practices: approxim ately 240 GPs).
Data-analysis and presentation/synthesis
Data collection, processing and analyses will be done w ith 
SPSS/PC, version 12 and 15. Variables will be analysed 
w ith the param etric Student-t test or the non-param etric 
U-test o f M ann-W hitney (W ilcoxon ranksum test) and the 
W ilcoxon-test for two unpaired  samples. To com pare the
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effects betw een different groups repeated measures 
AN(C)OVA and linear regression m odels will be used. 
Analyses will be done according to  the intention-to-treat- 
principal. In case o f m issing values, non-com pliance, loss- 
to-follow-up, drop-outs and protocol deviations also per- 
protocol analyses will be done for the econom ic evalua­
tion  only. To com pare GPs using the nurse specialist and 
GPs w ho do not, per-protocol analyses will be performed.
Economic evaluation
A cost-effectiveness analysis will be perform ed from  the 
societal perspective. In this analysis the increm ental 
health  effects and  the increm ental costs o f involving a 
nurse specialist in  prim ary care for adult patients w ith UI, 
as com pared to  usual care, will be weighted. The m ajor 
potential health  effects o f  involving a nurse specialist are 
likely to  result from  an increase in  the u tilization o f  avail­
able therapies w ith proven effectiveness for UI, such as 
b ladder training and /o r pelvic floor muscle training. The 
EuroQol will be used to  calculate quality adjusted life 
years (QALYs) following the algorithm  developed by 
D olan et al. [45]. Health care costs, productivity costs and 
patient and family costs will be included in  the analysis. 
Health care costs (the use o f diagnostics, treatm ent and 
incontinence pads) and productivity costs, tim e costs and 
travel costs will be collected using b o th  registration sys­
tems and retrospective cost questionnaires. The cost ques­
tionnaire will be filled in  by the patients at baseline, 3, 6, 
9 and  12 m onths. Cost calculation will be based on  real 
prices or on  un it prices from  the Dutch Guideline for Cost 
Calculation [46]. For the nurse specialist a cost price cal­
culation will be performed. Costs associated w ith produc­
tivity loss will be calculated using the friction costs 
m ethod  [46]. In case o f household, or o ther unpa id  activ­
ities, shadow  prices will be used. W hen clinical relevant 
effects o f decreasing the im pact o f UI o n  daily life, and 
thus the use o f  incontinence pads, will be found during 
the one year o f the study, a Markov type health  state tran­
sition m odel will be used to  calculate the long-term  cost- 
effectiveness o f the intervention [see Additional file 4].
Discussion
In this paper we describe the study protocol of, to  our 
knowledge, the first random ized controlled trial on  care 
for UI patients in  general practice tha t includes a full eco­
nom ic evaluation and  cost-effectiveness m odelling exer­
cise from  the societal perspective.
Next to this, despite the growing em phasis in  the Nether­
lands on  involving nurse specialists in  general practice, 
specifically for UI this is still unfam iliar and  the delega­
tion  o f tasks to  a nurse specialist can be considered as a 
new approach [17,47].
(Potentia l) strengths o f the study protocol
-  The study design
The choice for a pragmatic design ensures tha t the inter­
vention  is as close as possible to treatm ent options in  clin­
ical practice (including 'cascades' o f  patien t m anagem ent 
choices). This makes im plem entation in  the future easier. 
A care protocol w ith the preferred route via the nurse spe­
cialist is used. GPs will be well inform ed and  stim ulated 
to  follow this care protocol. Despite this, there is a chance 
tha t GPs will no t optim ally use the nurse specialist 
because o f perceptions o f GPs or unfam iliarity w ith this 
new professional. For this reason perceptions such as w ill­
ingness to  use the nurse specialist, expectations, first expe­
riences and reasons/prom oting or ham pering factors for 
GPs to  use or no t to use this route will be m easured and 
actively m onitored.
-  Recruitm ent strategy
A particular strength is the recruitm ent strategy. Both new 
and already diagnosed UI patients are eligible. By recruit­
ing already diagnosed UI patients we are likely to  also 
include the m ajority o f UI patients w ho m ainly use pads 
and did n o t receive adequate conservative treatm ent 
before. In addition, this approach will be helpful to 
include the required num ber o f patients in  the available 
tim e period.
-  Randomization approach
A th ird  strength o f our study protocol is the random iza­
tion  approach, in  which allocation is concealed and  done 
by an external independent person. R andom ization is 
done on  patient level. An alternative w ould be that GPs 
w ould be random ized instead o f patients. As GPs in  the 
control group probably will have difficulties to  include 
enough patients, this alternative seem ed unfavourable.
-  Com petences o f  the nurse specialists
A nother strength o f our study protocol is that all nurses 
are trained and  assessed in  a uniform  way to  assure that 
the intervention will be carried out conform  the interven­
tion  protocol in  all four regions. To be able to get insight 
in to  their actual performance, all nurses will register their 
actions during all patient visits. This registration will be 
used to  search for factors related to  the intervention proc­
ess that m ight influence the effectiveness o f the interven­
tion. It m ay also show  an individual learning curve, as this 
intervention is new for the nurses.
-  Outcome m easurem ents
Diagnosing the type o f UI is prim arily done by the GP. 
Since we really w ant to  m im ic routine practice as close as 
possible we did  no t choose for objective m easurem ents to 
confirm  the diagnose o f the type o f  UI by urodynam ic 
testing. N either did we choose for a pad  test to  measure 
the severity o f  UI. O n the one h and  because we felt th a t a
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pad test w ould be too  m uch o f a burden  especially for the 
control group only receiving usual care. O n the other 
h and  because a pad test may act as a feedback which 
m ight influence the usual care too  m uch. Furthermore, in  
the analyses by taking the baseline scores in to  account the 
inform ation bias resulting from  subjective self-reports 
will be reduced. Moreover, the self-reported data on  
healthcare use and costs will be validated by data from  
external sources like insurance com panies (patients will 
give their inform ed consent).
(Potentia l) lim itations o f the study protocol
-  Participant selection
Selection o f  participants m ay lim it generalization o f the 
results o f this study as selective non-response o f patients 
as well as selective drop-out and selective refusal o f GPs 
are possible.
Selective refusal o f patients to  participate m ight be 
assum ed as some patients label UI as an accepted aspect 
o f norm al aging or do no t experience adverse conse­
quences. Possibly, such UI patients will refuse m ore often 
to  participate than  other UI patients. The same m ight be 
assum ed about the m ore com plex UI patients, w ho are 
severely burdened  by m ulti-m orbidity, and m ight be 
afraid to  becom e even m ore burdened  w ith participating 
in  the study m easurem ents. To lim it such selective refusal 
patients living in  care -  and  nursing hom es are excluded 
from  the study. To prevent selective drop out o f patients 
in  poor health  states, the questionnaires are designed to 
m inim ize com pletion burden. Selective refusal o f GPs to 
participate is anticipated from  GPs already working w ith 
(in)continence nurses or specialised physical therapists.
R andom ization on  patient level could lead to  contam ina­
tion, and  bias the results o f this study. However, the influ­
ence o f  contam ination  is m inim ised, because patients in  
the usual care group have no  access to the intervention of 
the nurse specialist. Nevertheless, it is possible that partic­
ipating GPs are encouraged by the study to give m ore 
attention to  the UI patients participating in  the usual care 
group. As a result our findings m ay be conservative.
Conclusion
The study will provide evidence w hether the availability of 
a nurse specialist in  a new role as substitute for the general 
practitioner leads to  m ore effective and efficient care for 
adult urinary incontinence patients. Furthermore, the 
results will show w hether this availability improves the 
quality o f  life o f patients and the satisfaction o f patients, 
general practitioners and  other care providers. If this inter­
vention  proves to  be effective, im plem entation o f this 
intervention is considered and  anticipated.
First results o f this study will becom e available au tum n 
2008.
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Intervention nurse specialist: diagnostic process, evaluation and therapeu­
tic process. This document gives a detailed description of process of the 
intervention given by the nurse specialists.
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A dditional file 3
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A dditional file 4
Modelling approach. This document explains how the long-term cost- 
effectiveness of the intervention will be calculated when clinical relevant 
effects of decreasing the impact of UI on daily life, and thus the use of 
incontinence pads, will be found during the one year of the study.
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